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Experimental Section 
 
Protein isolation: Following previously described protocols[1–3], Azotobacter vinelandii 
cells were grown aerobically and nitrogenase expression was induced by ammonia 
depletion. Nitrogenase proteins from A. vinelandii were purified anaerobically using 
Schlenk line techniques and assessed for activity using acetylene reduction assays. The 
specific activity for acetylene reduction averaged 2010 ± 100 nmol of ethylene min-1 mg-1 
for Mo-Fe protein and 1970 ± 100 nmol of ethylene min-1 mg-1 for Fe-protein. Nitrogenase 
protein solutions were buffered in 50 mM Tris/HCl pH 7.5, 200 mM NaCl, 5 mM sodium 
dithionite. Ti(III) citrate was prepared from a 1.5% solution of Ti(III) chloride in 0.2 M 
sodium citrate, neutralized to pH 7.0 by titrating in sodium carbonate.   
 
Crystallization: All crystals were obtained by vapor-diffusion sitting-drop techniques in 
95% Ar, 5% H2 atmosphere, 25°C. A. vinelandii Fe-protein was used at concentrations 
between 20-40 mg/mL. 
 
ADP-bound crystal formation: The dithionite-reduced, ADP-bound crystals were identified 
from a condition containing Fe-protein and MoFe-protein at a 4:1 molar ratio, with 1 mM 
AlCl3, 10 mM NaF, 5 mM ATP and 10 mM MgCl2 to form an aluminum fluoride stabilized 
protein complex. A 100 kDa molecular weight cut-off concentration unit (EMD Millipore) 
was used to separate free Fe-protein, but Fe-protein was retained in the mixture used for 
crystal trials. Evidently, a population of Fe-protein hydrolyzed MgATP, resulting in 
crystallized Fe-protein-MgADP. The crystals were obtained in 40% PEG 400, 0.17 mM 
Cymal 7, 0.1 M HEPES pH 7.5, 5 mM dithionite. Oxidized structures were obtained by 
first growing crystals in the dithionite-reduced, MgADP condition, and soaking the crystals 
in 5 mM indigocarmine (IDS) for 1 –  5 min. The progress of the crystal soaks was 
apparent by the change in color of the crystals from ~brown to ~green over time. Crystals 
were cryo-protected with 2-methyl-2, 4-pentanediol (MPD). Ti(III) citrate-reduced protein 
was screened for an ADP-bound form, but the trials did not yield crystals. 
 
Nucleotide-free crystal formation: Crystals of the dithionite-reduced, nucleotide free state 
were grown in a solution of 40% PEG 1000, 0.2 M NaCl, 0.1 M MES/OH pH 6.5, 10% 
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2,2,2-trifluoroethanol, 5 mM dithionite, and cryo-protected with 2-methyl-2, 4-pentanediol 
(MPD). All-ferrous crystal structures were grown in conditions of 37% PEG 3350, 0.05 M 
NaCl, 0.1 M Bis/Tris pH 5.5, 5 mM Ti(III) citrate. Crystals of the IDS-oxidized nucleotide-
free form were prepared from the dithionite-reduced nucleotide free crystals, but yielded 
poor diffraction.  
 
Structure determination: Crystallographic data were collected at the Stanford Synchrotron 
Radiation Lightsource at beamline 12-2, using 0.5° steps over 360°. The high-resolution 
Fe protein structure was obtained in the orthorhombic space group P22121 with cell 
constants of a = 45.7 Å, b= 74.6 Å, c= 75.2 Å (for additional crystallographic statistics, 
see Table S2). The crystals grew in space group P22121, with one subunit per asymmetric 
unit (previous Fe-protein crystals have exclusively contained the full dimer in the 
asymmetric unit). Datasets were collected at multiple wavelengths (see Table S3) across 
the iron K-edge (7121 eV). Spatially resolved anomalous dispersion refinement 
(SpReAD) analysis was performed as previously reported by refining Δf’’ values against 
the anomalous differences for individual structure factors[4,5], with phases calculated from 
the structure refined against the high-resolution dataset  collected at 12,000 eV. The data 
were integrated with XDS[6] and merged with SCALA[7]. The high-resolution structures 
collected at 12,000 eV were phased with PHASER by molecular replacement using one 
monomer of the previously determined Fe protein structure (1G5P)[8], with the [4Fe:4S] 
cluster omitted. For the refinement, the standard ligands SF4 and FES were used from 
the CCP4 library (FES Fe-Fe bond distance: 3.06 Å, Fe-S bond lengths: 2.20 Å. SF4 Fe-
Fe bond lengths: 3.10 Å, Fe-S bond distance: 2.19 Å). We note that the Fe-Fe distances 
in these standard groups are significantly longer than observed in actual FeS clusters 
(~2.70 Å). The holo structures were refined with Refmac5 in the CCP4 suite, and provided 
the phases for the high-energy datasets[9]. Model building was performed in Coot[10]. For 
an overlay of all SpReAD profiles, see Figure S3. The nucleotide observed was assigned 
as MgADP based on the coordination sphere of the Mg2+ ion; we observed a 
hexacoordinate ion adjacent to the ADP molecule, liganded to four waters, Ser16 and a 
phosphate from ADP. The Mg2+-ligand distances are ~2.1 Å, consistent with Mg2+(H2O) 
complexes[11]. An AlF4- molecule would have predicted ~1.7 Å bond lengths for Al-F[12], 
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with a square planar geometry and a binding site distinct from the Mg2+ ion, as observed 
in the 1M34 complex structure[13]. 
 
The coordinates and structure factors have been deposited in the RCSB Protein Data 
Bank entries: 6N4J (Ti(III)-citrate reduced, nucleotide free form), 6N4K (DT-reduced, 
nucleotide free form), 6N4L (DT-reduced, ADP-bound form), 6N4M (IDS-oxidized, ADP-
bound form).  
 
Electron paramagnetic resonance: EPR experiments were performed on an X-band 
Bruker EMX CW-EPR spectrometer with an ESR 900 liquid helium/nitrogen flow-through 
cryostat (Oxford Instruments) at powers ranging from 2 mW to 10 mW at 10 K. The 
modulation amplitude was 3 G and the modulation frequency 100 kHz, with a 40 ms time 
constant and 167.7 s sweep time. In the solution-state sample, the protein concentration 
was 20 mg/mL (0.31 mM) in 18.25% PEG 1000, 0.1 M sodium chloride, 0.05 M MES/OH 
pH 6.5 and 10 mM sodium dithionite. The crystal slurry sample was prepared by growing 
A. vinelandii Fe-protein crystals in 2 μL sitting drops. 115 clear drops with crystals were 
pooled in reservoir buffer (36.5% PEG 1000, 0.2 M sodium chloride, 0.1 M MES/OH pH 
6.5, 10 mM sodium dithionite) and crystals were broken using a cryo-loop. Samples were 
frozen in liquid nitrogen in 4 mm thin-wall quartz tubes (Wilmad-Lab Glass). Simulations 
were performed using GeeStrain5[14]. Simulation parameters: g = (1.85, 1.927, 2.00), σg 
= (0.023, 0.010, 0.045).   
  5 
 
 
 
Figure S1. Overlay of the previously reported Fe-protein structure (1G5P, gray) and the 
1.13 Å-resolution, Mg-ADP-bound structure determined in this work (red). C-termini are 
indicated with gray and red arrows, respectively.  
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Figure S2. Fe-S distances in the cluster across oxidation states. Fe1-Fe4 are 
coordinated by Sγ of Cys A97, Cys A132, Cys B97 and Cys B132, respectively.  
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Figure S3. SpReAD profiles for [4Fe:4S]2+, 1+ and 0 states with average profiles for the 
P-cluster and FeMo-cofactor[5]. 
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0+ 1+ 1+ (MgADP) 2+ (MgADP) 
1G5P 0.627 0.666 0.745 0.687 
1G1M 0.322 0.570 0.727 0.648 
1FP6 0.693 0.731 0.576 0.449 
 
Table S1. Cα RMSD (Å) between Fe-protein in different oxidation and nucleotide states 
reported in here and previously, including the nucleotide free forms of the [4Fe:4S]1+ 
(PDB entry 1G5P) and [4Fe:4S]0 (PDB entry 1G1M) oxidation states, and the ADP-
bound form of the [4Fe:4S]1+ state (PDB entry 1FP6) using Chimera[15]. 
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 0+ 
(-MgADP) 
0+ 
SpReAD 
1+ 
(-MgADP) 
1+ 
SpReAD 
1+ 
(+MgADP) 
1+ 
SpReAD 
2+ 
(+MgADP) 
2+ 
SpReAD 
Wavelength 
(eV) 12000 7100-7130 12000 7100-7130 14000 7080-8010 12000 7080-8010 
Resolution 
range (Å) 
44.68-1.95 
(2.06-1.95) 
[(2.27-
2.05)] 
39.29-1.76 
(1.82-1.76) [(2.06-2.05)] 
39.01-1.13 
(1.15-1.13) 
[(2.0- 
1.80)] 
39.03-1.58 
(1.67-1.58) 
[(2.11-
1.92)] 
Space group P21  C2  P22121  P22121  
Unit cell 
parameters 57.25 Å  103.81 Å  45.59 Å  45.81 Å  
 93.05 Å  45.30 Å  74.63 Å  74.58 Å  
 60.77 Å  109.05 Å  75.40 Å  75.02 Å  
 90° 98.5° 
90°  
90° 96.6° 
90°  90° 90° 90°  90° 90° 90°  
Mean I/σ 11.2 (2.2)  8.1 (1.7)  17.6 (3.0)  31.2 (3.7)  
CC(1/2) 0.999 (0.930)  
0.998 
(0.847)  
0.999 
(0.915)  
1.000 
(0.897)  
Completeness 
(%) 
90.04 
(92.4) 
[96.6- 93.5 
(89.8-
79.5)] 
96.1 (55.7) [92.8-92.2 (76.1- 75.9)] 100 (99.9) 
[99.1- 85.4 
(90.0-
90.3)] 
98.9 (97.8) 
[95.0-94.4 
(71.3- 
68.9)] 
Rpim (all I+ & I-) 0.026 (0.211) 
[0.023-
0.021 
(0.384-
0.217)] 
0.019 
(0.278) 
[0.040-0.039 
(0.187-
0.143]) 
0.020 
(0.239) 
[0.020-
0.018 
(0.357-
0.107)] 
0.016 
(0.250) 
[0.017-
0.016 
(0.343-
0.235)] 
Total unique 
reflections 
41566 
(6160) 
[31666-
31542 
(4527-
2373)] 
51971 
(1562) 
[60171-
59309 
(7230-
7046)] 
96897 
(13986) 
[21154-
17961 
(1165-
1172] 
35382 
(5009) 
[23855-
16472 
(8519-
8092)] 
Bond length 
RMSD (Å) 0.021  0.017  0.029  0.023  
Bond angles 
RMSD (°) 2.430  2.232  2.658  2.158  
Rfactor 0.2108  0.1684  0.1364  0.1763  
Rfree 0.2471  0.2197  0.1539  0.1908  
 
Table S2. Crystallographic data table for Fe-protein in 0+, 1+, and 2+ oxidation states. 
Statistics in the high-resolution shell are indicated with round brackets. The data used in 
the SpReAD analysis is given as a range of values, denoted with square brackets.  
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Table S3. f’’ values as a function of energy for observed oxidation states, nucleotide free 
(top) and ADP-bound (bottom).  
 
  
Energy 
(eV) 
P-
cluster 
(2+) 
FeMo-
co 
(2.57+) 
S Fe 1 (TiCi) 
Fe 2 
(TiCi) 
Fe 3 
(TiCi) 
Fe 4 
(TiCi) 
Fe 1 
(DT) 
Fe 2 
(DT) 
Fe 3 
(DT) 
Fe 4 
(DT) 
7108 0.584 0.515 0.450 0.364 0.451 0.396 0.475 0.372 0.420 0.358 0.411 
7110 0.437 0.447 0.490 0.445 0.451 0.333 0.356 0.387 0.463 0.389 0.348 
7112 0.564 0.517 0.504 0.260 0.407 0.309 0.430 0.455 0.541 0.579 0.511 
7114 0.619 0.818 0.507 0.796 0.792 0.733 0.733 0.763 0.914 0.829 0.845 
7116 1.099 1.098 0.538 0.765 0.735 0.632 0.753 0.707 0.675 0.65 0.661 
7118 1.949 1.589 0.529 1.948 1.988 1.796 1.792 1.409 1.801 1.318 1.733 
7120 2.720 2.138 0.583 2.672 2.733 2.593 2.639 2.468 2.756 2.321 2.645 
7122 3.174 2.733 0.567 3.323 3.320 3.237 3.445 2.983 3.266 2.970 3.220 
7124 3.605 3.167 0.568 3.628 3.644 3.549 3.563 3.514 3.698 3.483 3.635 
7126 3.778 3.460 0.525 3.960 3.906 3.774 3.877 3.779 3.926 3.624 3.683 
7128 3.797 3.638 0.529 3.938 3.967 3.916 3.957 3.648 3.917 3.878 3.766 
7133 3.773 3.717 0.534 3.963 3.886 3.990 4.065 3.766 3.803 3.652 3.735 
Energy (eV) P-cluster (2+) 
FeMo-
cofactor 
(2.57+) 
S Fe 1,3 (DT +ADP) 
Fe 2,4 
(DT+ADP) 
Fe 1,3  
(IDS + ADP) 
Fe 2,4  
(IDS + ADP) 
7108 0.584 0.515 0.450 -- -- 0.370 0.350 
7110 0.437 0.447 0.490 0.382 0.373 0.387 0.467 
7112 0.564 0.517 0.504 0.582 0.655 0.999 0.878 
7114 0.619 0.818 0.507 0.600 0.518 0.568 0.430 
7116 1.099 1.098 0.538 0.700 0.864 0.686 0.541 
7118 1.949 1.589 0.529 1.382 1.700 0.496 0.609 
7120 2.720 2.138 0.583 2.273 2.527 2.016 1.876 
7122 3.174 2.733 0.567 2.891 3.164 3.018 3.206 
7124 3.605 3.167 0.568 3.555 3.673 3.679 3.529 
7126 3.778 3.460 0.525 3.927 3.764 4.122 4.152 
7128 3.797 3.638 0.529 -- -- 4.200 4.200 
7133 3.773 3.717 0.534 4.000 4.018 4.466 4.471 
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